The robotic-assisted surgery systems market is expected to grow from US$ 7,831.93 million in 2022 to US$ 23,816.80 million by 2030; it is anticipated to record a CAGR of 14.9% from 2022 to 2030.

Coverage: Product Type (System, Consumables and Accessories, and Software and Services), Application (Gynecological Surgery, Cardiovascular, Neurosurgery, Orthopedic Surgery, Laparoscopy, Urology, and Other Applications), End User (Hospitals, Ambulatory Surgery Centers, and Other End Users) and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa) 

Avail Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00004753/

The increasing prevalence of chronic diseases drives the growth of the drug discovery services market.

Throughout the projected period, increasing research studies utilizing robotic-assisted operations are anticipated to fuel market expansion. For instance, in September 2022, a study comparing robotic-assisted fluoroscopic-guided and ultrasound-guided renal access for percutaneous nephrolithotomy was carried out by the Nagoya City University (NCU) Graduate School of Medical Sciences team. The study’s findings supported the revolutionary robotic device’s safety and ease of use, which may lessen the training burden on surgeons and enable more hospitals to perform PCNL procedures. This method, which uses robotics driven by artificial intelligence, may open the door to the automation of comparable interventional surgery procedures, which might speed up the process and possibly lower the risk of complications.

Additionally, the market for robotically assisted surgical systems is expanding as a result of the rise in chronic disease cases and the growing popularity of minimally invasive surgeries due to their advantages over open surgery and success rate. For example, according to news released by The Hindu in August 2022, Apollo Health City in Hyderabad has completed more than 500 robotically assisted gynecological procedures in India. As a result, the country’s growing use of MIS procedures—which are less painful than open surgery—is fueling the market’s rise.

In November 2022, the first urological treatment in north India to be completed with the Hugo robotic-assisted surgery (RAS) system was also reported by India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, and Venkateshwar Hospital in Delhi.

The robotic-assisted surgery systems market is divided on the basis of process, type, molecule type, therapeutic area, and end user. Based on the process, the robotic assisted surgery systems market is segmented into target selection and validation, hit to lead identification, and others – assay development and screening, etc. By type, the robotic assisted surgery systems market is segmented into biology services, medicinal chemistry drug metabolism, and pharmacokinetics. In terms of molecule type, the robotic assisted surgery systems market is classified as biologics and small molecules. On the basis of therapeutic areas, the robotic assisted surgery systems market is differentiated into cardiovascular diseases, oncology, neurology, diabetes, respiratory diseases, and others. Furthermore, the end-user segment is classified into Pharmaceutical and Biotechnology Companies, Academic Institutes, and Others.

 

About Us:

The Insight Partners is a market research solution and consultation company. Specializing in syndicate market research, our team helps clients in their hunt for revenue pockets in several industries. A team of 250+ research experts is dedicated to offering the most relevant, data-driven, and trustworthy market insights and consultation.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us

The Insight Partners

Phone: +1-646-491-9876

E-mail: [email protected]